

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.37557610 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.89070242 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.77358609 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.77224126 |
| 5 | vocalization behavior (GO:0071625) | 5.49503728 |
| 6 | glutamate secretion (GO:0014047) | 5.33372440 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.30889216 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.18410230 |
| 9 | locomotory exploration behavior (GO:0035641) | 5.17298674 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.83984410 |
| 11 | L-amino acid import (GO:0043092) | 4.83921140 |
| 12 | protein localization to synapse (GO:0035418) | 4.82516776 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.70455934 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.67284283 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.66779425 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.60570357 |
| 17 | amino acid import (GO:0043090) | 4.49042048 |
| 18 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 4.47961997 |
| 19 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.28487242 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.20534798 |
| 21 | exploration behavior (GO:0035640) | 4.12973307 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.09142244 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.05200863 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 3.99700202 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 3.96145900 |
| 26 | * regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.95976829 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.95423377 |
| 28 | neurotransmitter transport (GO:0006836) | 3.95181892 |
| 29 | proline transport (GO:0015824) | 3.94756733 |
| 30 | activation of protein kinase A activity (GO:0034199) | 3.89093714 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 3.88212872 |
| 32 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.87714467 |
| 33 | central nervous system myelination (GO:0022010) | 3.78134500 |
| 34 | axon ensheathment in central nervous system (GO:0032291) | 3.78134500 |
| 35 | neuromuscular process controlling posture (GO:0050884) | 3.76851276 |
| 36 | synaptic transmission, glutamatergic (GO:0035249) | 3.74512569 |
| 37 | dendritic spine morphogenesis (GO:0060997) | 3.72235846 |
| 38 | glutamate receptor signaling pathway (GO:0007215) | 3.72123531 |
| 39 | positive regulation of dendritic spine development (GO:0060999) | 3.69822585 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.69644903 |
| 41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.66033988 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 3.65733628 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.63981841 |
| 44 | sodium ion export (GO:0071436) | 3.63890580 |
| 45 | long-term memory (GO:0007616) | 3.63502610 |
| 46 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.60933427 |
| 47 | neuron recognition (GO:0008038) | 3.59650064 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.58459745 |
| 49 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.58331522 |
| 50 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.54287255 |
| 51 | regulation of neurotransmitter levels (GO:0001505) | 3.50505908 |
| 52 | cerebellar granule cell differentiation (GO:0021707) | 3.48595196 |
| 53 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.47112822 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.47095273 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.46863474 |
| 56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.45042216 |
| 57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.44765643 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44392710 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.44008585 |
| 60 | transmission of nerve impulse (GO:0019226) | 3.40681282 |
| 61 | regulation of synapse structural plasticity (GO:0051823) | 3.39254771 |
| 62 | regulation of synapse maturation (GO:0090128) | 3.39051396 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.37370698 |
| 64 | membrane hyperpolarization (GO:0060081) | 3.32865383 |
| 65 | response to histamine (GO:0034776) | 3.30200397 |
| 66 | regulation of dendritic spine development (GO:0060998) | 3.28441334 |
| 67 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.27013723 |
| 68 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.25066159 |
| 69 | positive regulation of synapse maturation (GO:0090129) | 3.21156180 |
| 70 | regulation of synaptic plasticity (GO:0048167) | 3.20915736 |
| 71 | axonal fasciculation (GO:0007413) | 3.18990155 |
| 72 | cellular sodium ion homeostasis (GO:0006883) | 3.17658762 |
| 73 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.16896924 |
| 74 | long-term synaptic potentiation (GO:0060291) | 3.15440237 |
| 75 | cell communication by electrical coupling (GO:0010644) | 3.14717090 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.14266941 |
| 77 | regulation of neurotransmitter transport (GO:0051588) | 3.12401882 |
| 78 | membrane depolarization during action potential (GO:0086010) | 3.11987777 |
| 79 | mating behavior (GO:0007617) | 3.09666990 |
| 80 | presynaptic membrane assembly (GO:0097105) | 3.08819594 |
| 81 | vesicle transport along microtubule (GO:0047496) | 3.06604627 |
| 82 | postsynaptic membrane organization (GO:0001941) | 3.05916986 |
| 83 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.04797285 |
| 84 | intraspecies interaction between organisms (GO:0051703) | 3.04416923 |
| 85 | social behavior (GO:0035176) | 3.04416923 |
| 86 | acidic amino acid transport (GO:0015800) | 3.04267408 |
| 87 | detection of calcium ion (GO:0005513) | 3.00549712 |
| 88 | membrane depolarization (GO:0051899) | 3.00252294 |
| 89 | positive regulation of neurotransmitter transport (GO:0051590) | 3.00148139 |
| 90 | synapse assembly (GO:0007416) | 2.99334597 |
| 91 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.99004532 |
| 92 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.97708306 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95716028 |
| 94 | * synaptic transmission (GO:0007268) | 2.95427211 |
| 95 | glycine transport (GO:0015816) | 2.95244686 |
| 96 | positive regulation of synaptic transmission (GO:0050806) | 2.93611209 |
| 97 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.93378453 |
| 98 | innervation (GO:0060384) | 2.92343923 |
| 99 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.92160995 |
| 100 | startle response (GO:0001964) | 2.91807640 |
| 101 | dendrite morphogenesis (GO:0048813) | 2.91628017 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 2.89665505 |
| 103 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.88281955 |
| 104 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.88142572 |
| 105 | response to auditory stimulus (GO:0010996) | 2.87823485 |
| 106 | potassium ion homeostasis (GO:0055075) | 2.87653814 |
| 107 | calcium ion-dependent exocytosis (GO:0017156) | 2.87451257 |
| 108 | regulation of synaptic transmission (GO:0050804) | 2.86197415 |
| 109 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.85439155 |
| 110 | synaptic vesicle transport (GO:0048489) | 2.83690213 |
| 111 | establishment of synaptic vesicle localization (GO:0097480) | 2.83690213 |
| 112 | regulation of ARF protein signal transduction (GO:0032012) | 2.83424472 |
| 113 | presynaptic membrane organization (GO:0097090) | 2.82950467 |
| 114 | learning (GO:0007612) | 2.82878101 |
| 115 | potassium ion import (GO:0010107) | 2.82462521 |
| 116 | neuronal ion channel clustering (GO:0045161) | 2.81863007 |
| 117 | C4-dicarboxylate transport (GO:0015740) | 2.80310567 |
| 118 | neurotransmitter uptake (GO:0001504) | 2.78481582 |
| 119 | regulation of cell communication by electrical coupling (GO:0010649) | 2.75044069 |
| 120 | positive regulation of Rap GTPase activity (GO:0032854) | 2.72431104 |
| 121 | cell communication involved in cardiac conduction (GO:0086065) | 2.72003980 |
| 122 | positive regulation of dendrite development (GO:1900006) | 2.71745511 |
| 123 | regulation of dendrite morphogenesis (GO:0048814) | 2.71165677 |
| 124 | L-glutamate transport (GO:0015813) | 2.69464435 |
| 125 | regulation of Rap GTPase activity (GO:0032317) | 2.64764455 |
| 126 | serotonin metabolic process (GO:0042428) | 2.64354482 |
| 127 | primary amino compound metabolic process (GO:1901160) | 2.63171917 |
| 128 | vesicle docking involved in exocytosis (GO:0006904) | 2.60642788 |
| 129 | positive regulation of fibroblast migration (GO:0010763) | 2.60162883 |
| 130 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.55518862 |
| 131 | vesicle docking (GO:0048278) | 2.52375347 |
| 132 | dicarboxylic acid transport (GO:0006835) | 2.48865404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.06188093 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.58675796 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03923311 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94807334 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84598063 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74103867 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.53183941 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50996045 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50996045 |
| 10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48861811 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47985622 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.46922383 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45061709 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36070140 |
| 15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33281721 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33080394 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.32407084 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22683057 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15718019 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.14279550 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12855473 |
| 22 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08148931 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02843265 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98873578 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97266035 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.97145741 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93708500 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91111556 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88491170 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85155504 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78858742 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77263848 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66116443 |
| 34 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.65683450 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52572649 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49687129 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.48457215 |
| 38 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.47531548 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46419873 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45915618 |
| 41 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.45870839 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45521207 |
| 43 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43960917 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43300743 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39786776 |
| 46 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38395576 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37799972 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36438741 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36111146 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36102066 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35152464 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33429474 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32665383 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32307009 |
| 55 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32118324 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31471003 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30793180 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30686745 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.27215468 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25663332 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25328002 |
| 62 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.25245917 |
| 63 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21051786 |
| 64 | * AR_19668381_ChIP-Seq_PC3_Human | 1.20922983 |
| 65 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20874740 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20587577 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19186365 |
| 68 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19126711 |
| 69 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17994848 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16590723 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14952999 |
| 72 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14896060 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14020555 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13892482 |
| 75 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13760934 |
| 76 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12752177 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11397027 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10755523 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09686533 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09638712 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08336457 |
| 82 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07759601 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07729813 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07478955 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07448550 |
| 86 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.05359769 |
| 87 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04666115 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03665067 |
| 89 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03441701 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03441701 |
| 91 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02811859 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02136860 |
| 93 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02120029 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00553022 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00344265 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00028869 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99739631 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97955926 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96682578 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96271296 |
| 101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96223837 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95836802 |
| 103 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95503291 |
| 104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95000118 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94855117 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93875898 |
| 107 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93454055 |
| 108 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93330109 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90684781 |
| 110 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.90398737 |
| 111 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90368990 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90155919 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89873825 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89311116 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89126322 |
| 116 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.88946437 |
| 117 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88225092 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 0.88036821 |
| 119 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87483298 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86882198 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86728897 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85844967 |
| 123 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85589052 |
| 124 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82705996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.82237102 |
| 2 | MP0003880_abnormal_central_pattern | 5.00064133 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.97289889 |
| 4 | MP0004270_analgesia | 3.43344527 |
| 5 | MP0009745_abnormal_behavioral_response | 3.32227230 |
| 6 | MP0009046_muscle_twitch | 3.19336528 |
| 7 | MP0002064_seizures | 3.17826657 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.08586543 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.06469594 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.94008789 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.66979974 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.60412225 |
| 13 | MP0002272_abnormal_nervous_system | 2.53250474 |
| 14 | MP0001486_abnormal_startle_reflex | 2.53198797 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.41929506 |
| 16 | MP0002822_catalepsy | 2.22002976 |
| 17 | MP0002736_abnormal_nociception_after | 2.19020756 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.14519331 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.09692761 |
| 20 | MP0006276_abnormal_autonomic_nervous | 2.04991388 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 2.04723219 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.01251837 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.98370397 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.96344339 |
| 25 | MP0001970_abnormal_pain_threshold | 1.87085683 |
| 26 | MP0003122_maternal_imprinting | 1.85145038 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.82930321 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.76355305 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.76080249 |
| 30 | MP0004924_abnormal_behavior | 1.76080249 |
| 31 | MP0008569_lethality_at_weaning | 1.72822631 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.69268191 |
| 33 | MP0003787_abnormal_imprinting | 1.67843673 |
| 34 | MP0002184_abnormal_innervation | 1.66330372 |
| 35 | MP0003329_amyloid_beta_deposits | 1.63942857 |
| 36 | MP0001984_abnormal_olfaction | 1.61678275 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.58625248 |
| 38 | MP0001502_abnormal_circadian_rhythm | 1.55037470 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.54095854 |
| 40 | MP0004858_abnormal_nervous_system | 1.51338554 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.50419322 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.50135677 |
| 43 | MP0000778_abnormal_nervous_system | 1.49217445 |
| 44 | MP0003879_abnormal_hair_cell | 1.47984848 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.41890573 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.38593038 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.35466100 |
| 48 | MP0000955_abnormal_spinal_cord | 1.35231879 |
| 49 | MP0004885_abnormal_endolymph | 1.35165115 |
| 50 | MP0002066_abnormal_motor_capabilities/c | 1.34915547 |
| 51 | MP0004142_abnormal_muscle_tone | 1.33091214 |
| 52 | MP0003633_abnormal_nervous_system | 1.30345672 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.29326424 |
| 54 | MP0002229_neurodegeneration | 1.24868584 |
| 55 | MP0001529_abnormal_vocalization | 1.24163944 |
| 56 | MP0005253_abnormal_eye_physiology | 1.20823627 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.20075345 |
| 58 | MP0002090_abnormal_vision | 1.20011548 |
| 59 | MP0001905_abnormal_dopamine_level | 1.18828098 |
| 60 | MP0000751_myopathy | 1.12940013 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 1.06381830 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.05755827 |
| 63 | MP0005410_abnormal_fertilization | 1.04145934 |
| 64 | MP0002638_abnormal_pupillary_reflex | 1.03233881 |
| 65 | MP0003631_nervous_system_phenotype | 1.02761418 |
| 66 | MP0008961_abnormal_basal_metabolism | 0.99339781 |
| 67 | MP0008872_abnormal_physiological_respon | 0.99224986 |
| 68 | MP0003868_abnormal_feces_composition | 0.96941903 |
| 69 | MP0002069_abnormal_eating/drinking_beha | 0.96151150 |
| 70 | MP0005535_abnormal_body_temperature | 0.95891025 |
| 71 | MP0002152_abnormal_brain_morphology | 0.95368665 |
| 72 | MP0001188_hyperpigmentation | 0.94329392 |
| 73 | MP0004215_abnormal_myocardial_fiber | 0.94124615 |
| 74 | MP0005409_darkened_coat_color | 0.91989154 |
| 75 | MP0008877_abnormal_DNA_methylation | 0.91834584 |
| 76 | MP0003690_abnormal_glial_cell | 0.87448665 |
| 77 | MP0001348_abnormal_lacrimal_gland | 0.87401667 |
| 78 | MP0001299_abnormal_eye_distance/ | 0.85762923 |
| 79 | MP0004085_abnormal_heartbeat | 0.85705806 |
| 80 | MP0001177_atelectasis | 0.85693368 |
| 81 | MP0002752_abnormal_somatic_nervous | 0.85356129 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.85337381 |
| 83 | MP0003878_abnormal_ear_physiology | 0.84170586 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.84170586 |
| 85 | MP0003634_abnormal_glial_cell | 0.82697236 |
| 86 | MP0005670_abnormal_white_adipose | 0.82083938 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.81551364 |
| 88 | MP0004742_abnormal_vestibular_system | 0.80292323 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.79859625 |
| 90 | MP0008874_decreased_physiological_sensi | 0.79403137 |
| 91 | MP0003283_abnormal_digestive_organ | 0.78751845 |
| 92 | MP0003123_paternal_imprinting | 0.76577989 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.75409135 |
| 94 | MP0004036_abnormal_muscle_relaxation | 0.72202757 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.70536897 |
| 96 | MP0003121_genomic_imprinting | 0.69134613 |
| 97 | MP0004233_abnormal_muscle_weight | 0.68424996 |
| 98 | MP0001664_abnormal_digestion | 0.67865753 |
| 99 | MP0004484_altered_response_of | 0.67864954 |
| 100 | MP0000604_amyloidosis | 0.66091479 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.65263710 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.64769473 |
| 103 | MP0001346_abnormal_lacrimal_gland | 0.64549895 |
| 104 | MP0010329_abnormal_lipoprotein_level | 0.64462731 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.64447454 |
| 106 | MP0004130_abnormal_muscle_cell | 0.64348102 |
| 107 | MP0001915_intracranial_hemorrhage | 0.63242165 |
| 108 | MP0006138_congestive_heart_failure | 0.63169886 |
| 109 | MP0005187_abnormal_penis_morphology | 0.63081879 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.62829677 |
| 111 | MP0004043_abnormal_pH_regulation | 0.62827882 |
| 112 | MP0009672_abnormal_birth_weight | 0.61619378 |
| 113 | MP0003632_abnormal_nervous_system | 0.61582408 |
| 114 | MP0005195_abnormal_posterior_eye | 0.61529532 |
| 115 | MP0000920_abnormal_myelination | 0.61445754 |
| 116 | MP0003075_altered_response_to | 0.61176765 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.60323671 |
| 118 | MP0005499_abnormal_olfactory_system | 0.60323671 |
| 119 | MP0004084_abnormal_cardiac_muscle | 0.59002401 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.58693284 |
| 121 | MP0005448_abnormal_energy_balance | 0.56968354 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.55310376 |
| 123 | MP0001943_abnormal_respiration | 0.55222512 |
| 124 | MP0003119_abnormal_digestive_system | 0.55167561 |
| 125 | MP0010769_abnormal_survival | 0.50284655 |
| 126 | MP0008057_abnormal_DNA_replication | 0.49474098 |
| 127 | MP0005620_abnormal_muscle_contractility | 0.49233977 |
| 128 | MP0002133_abnormal_respiratory_system | 0.47734705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.76763759 |
| 2 | Myokymia (HP:0002411) | 5.62500675 |
| 3 | Focal seizures (HP:0007359) | 5.57167259 |
| 4 | Visual hallucinations (HP:0002367) | 5.40318314 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.01885560 |
| 6 | Atonic seizures (HP:0010819) | 5.00955715 |
| 7 | Febrile seizures (HP:0002373) | 4.76832936 |
| 8 | Absence seizures (HP:0002121) | 4.63504935 |
| 9 | Dialeptic seizures (HP:0011146) | 4.18089266 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.09445481 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.06809597 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.54301346 |
| 13 | Central scotoma (HP:0000603) | 3.34340035 |
| 14 | Broad-based gait (HP:0002136) | 3.31351504 |
| 15 | Action tremor (HP:0002345) | 3.26647260 |
| 16 | Papilledema (HP:0001085) | 3.24792398 |
| 17 | Abnormal eating behavior (HP:0100738) | 3.19310065 |
| 18 | Hyperventilation (HP:0002883) | 3.15742726 |
| 19 | Depression (HP:0000716) | 3.15112313 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.08672319 |
| 21 | Truncal ataxia (HP:0002078) | 3.07569517 |
| 22 | Poor eye contact (HP:0000817) | 3.05255462 |
| 23 | Ankle clonus (HP:0011448) | 3.01245588 |
| 24 | Anxiety (HP:0000739) | 2.98101291 |
| 25 | Congenital stationary night blindness (HP:0007642) | 2.96907666 |
| 26 | Hepatoblastoma (HP:0002884) | 2.96779713 |
| 27 | Progressive inability to walk (HP:0002505) | 2.94700220 |
| 28 | Abnormal social behavior (HP:0012433) | 2.94421764 |
| 29 | Impaired social interactions (HP:0000735) | 2.94421764 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.93981202 |
| 31 | Mutism (HP:0002300) | 2.89303379 |
| 32 | Obstructive sleep apnea (HP:0002870) | 2.87692855 |
| 33 | Postural instability (HP:0002172) | 2.87349385 |
| 34 | Dysmetria (HP:0001310) | 2.81494482 |
| 35 | Annular pancreas (HP:0001734) | 2.80580062 |
| 36 | Ventricular fibrillation (HP:0001663) | 2.80352364 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.78571361 |
| 38 | Abnormality of macular pigmentation (HP:0008002) | 2.77665080 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.74522412 |
| 40 | Polyphagia (HP:0002591) | 2.69841895 |
| 41 | Genetic anticipation (HP:0003743) | 2.68431729 |
| 42 | Pheochromocytoma (HP:0002666) | 2.65179393 |
| 43 | Amblyopia (HP:0000646) | 2.61945945 |
| 44 | Arterial tortuosity (HP:0005116) | 2.59081740 |
| 45 | Hemiparesis (HP:0001269) | 2.58842090 |
| 46 | Epileptiform EEG discharges (HP:0011182) | 2.57428015 |
| 47 | Drooling (HP:0002307) | 2.56961433 |
| 48 | Excessive salivation (HP:0003781) | 2.56961433 |
| 49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.53629157 |
| 50 | Amyotrophic lateral sclerosis (HP:0007354) | 2.51391727 |
| 51 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.51137173 |
| 52 | Clonus (HP:0002169) | 2.49352653 |
| 53 | Agitation (HP:0000713) | 2.44745759 |
| 54 | Bradykinesia (HP:0002067) | 2.44537678 |
| 55 | Scanning speech (HP:0002168) | 2.40296751 |
| 56 | Hemiplegia (HP:0002301) | 2.38815122 |
| 57 | Neurofibrillary tangles (HP:0002185) | 2.38801070 |
| 58 | Status epilepticus (HP:0002133) | 2.37873786 |
| 59 | Hypsarrhythmia (HP:0002521) | 2.36117067 |
| 60 | Urinary urgency (HP:0000012) | 2.34603554 |
| 61 | Scotoma (HP:0000575) | 2.34589770 |
| 62 | Impaired smooth pursuit (HP:0007772) | 2.34570341 |
| 63 | Inability to walk (HP:0002540) | 2.34526489 |
| 64 | Spastic gait (HP:0002064) | 2.33981872 |
| 65 | Generalized myoclonic seizures (HP:0002123) | 2.31351920 |
| 66 | Intention tremor (HP:0002080) | 2.30459712 |
| 67 | Vascular tortuosity (HP:0004948) | 2.27767759 |
| 68 | Deep venous thrombosis (HP:0002625) | 2.27448164 |
| 69 | Absent speech (HP:0001344) | 2.25880332 |
| 70 | Neuroendocrine neoplasm (HP:0100634) | 2.25575314 |
| 71 | Resting tremor (HP:0002322) | 2.24542238 |
| 72 | Limb dystonia (HP:0002451) | 2.24287914 |
| 73 | Cerebral inclusion bodies (HP:0100314) | 2.23651435 |
| 74 | Gait imbalance (HP:0002141) | 2.22779505 |
| 75 | Tetraplegia (HP:0002445) | 2.21559022 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.19999267 |
| 77 | Bronchomalacia (HP:0002780) | 2.18970276 |
| 78 | Diplopia (HP:0000651) | 2.17231479 |
| 79 | Abnormality of binocular vision (HP:0011514) | 2.17231479 |
| 80 | Decreased motor nerve conduction velocity (HP:0003431) | 2.15801804 |
| 81 | Peripheral hypomyelination (HP:0007182) | 2.13801869 |
| 82 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.13620984 |
| 83 | Abnormal EKG (HP:0003115) | 2.12021764 |
| 84 | Failure to thrive in infancy (HP:0001531) | 2.12017365 |
| 85 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.11293337 |
| 86 | Abnormality of the lower motor neuron (HP:0002366) | 2.11194683 |
| 87 | Hypoventilation (HP:0002791) | 2.08271377 |
| 88 | Hyperthyroidism (HP:0000836) | 2.07006850 |
| 89 | Termporal pattern (HP:0011008) | 2.06091142 |
| 90 | Insidious onset (HP:0003587) | 2.06091142 |
| 91 | Torticollis (HP:0000473) | 2.04621923 |
| 92 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.04299601 |
| 93 | Lower limb muscle weakness (HP:0007340) | 2.02168054 |
| 94 | Blue irides (HP:0000635) | 1.99234111 |
| 95 | Psychosis (HP:0000709) | 1.98398736 |
| 96 | Prolonged QT interval (HP:0001657) | 1.97586094 |
| 97 | Dyschromatopsia (HP:0007641) | 1.94137572 |
| 98 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.93287279 |
| 99 | Stereotypic behavior (HP:0000733) | 1.93093385 |
| 100 | Dysmetric saccades (HP:0000641) | 1.92844921 |
| 101 | Bundle branch block (HP:0011710) | 1.91568650 |
| 102 | Papillary thyroid carcinoma (HP:0002895) | 1.89976372 |
| 103 | Focal dystonia (HP:0004373) | 1.88665829 |
| 104 | Specific learning disability (HP:0001328) | 1.87159598 |
| 105 | Gait ataxia (HP:0002066) | 1.86363309 |
| 106 | Hypercortisolism (HP:0001578) | 1.84264496 |
| 107 | Congenital primary aphakia (HP:0007707) | 1.84221412 |
| 108 | Craniofacial dystonia (HP:0012179) | 1.83876020 |
| 109 | Impaired vibratory sensation (HP:0002495) | 1.83384122 |
| 110 | Menstrual irregularities (HP:0000858) | 1.83025180 |
| 111 | Abnormality of the corticospinal tract (HP:0002492) | 1.81542144 |
| 112 | Rapidly progressive (HP:0003678) | 1.79404040 |
| 113 | Difficulty running (HP:0009046) | 1.77560121 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 1.77159805 |
| 115 | Rigidity (HP:0002063) | 1.75754008 |
| 116 | Alacrima (HP:0000522) | 1.75667850 |
| 117 | Delusions (HP:0000746) | 1.75016856 |
| 118 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74885714 |
| 119 | Megalencephaly (HP:0001355) | 1.74711258 |
| 120 | Abnormality of salivation (HP:0100755) | 1.74297514 |
| 121 | Sleep apnea (HP:0010535) | 1.74268147 |
| 122 | Increased circulating renin level (HP:0000848) | 1.72472092 |
| 123 | Slow progression (HP:0003677) | 1.70674469 |
| 124 | Akinesia (HP:0002304) | 1.69795170 |
| 125 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.69524392 |
| 126 | Lower limb asymmetry (HP:0100559) | 1.65767521 |
| 127 | Split foot (HP:0001839) | 1.65530369 |
| 128 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.65400582 |
| 129 | Aplasia of the phalanges of the hand (HP:0009802) | 1.65400582 |
| 130 | Aplasia involving bones of the extremities (HP:0009825) | 1.65400582 |
| 131 | Menorrhagia (HP:0000132) | 1.64504618 |
| 132 | Joint hemorrhage (HP:0005261) | 1.63807530 |
| 133 | Thickened helices (HP:0000391) | 1.63378211 |
| 134 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.63255766 |
| 135 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.63255766 |
| 136 | Cerebral hypomyelination (HP:0006808) | 1.59960677 |
| 137 | Deeply set eye (HP:0000490) | 1.59317874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.61353128 |
| 2 | MAP3K9 | 3.99884544 |
| 3 | MAP3K4 | 3.23098863 |
| 4 | EPHA4 | 3.11069583 |
| 5 | MARK1 | 3.00228809 |
| 6 | MINK1 | 2.67989542 |
| 7 | MAP2K7 | 2.60365820 |
| 8 | MAP3K12 | 2.48968236 |
| 9 | DAPK2 | 2.40426076 |
| 10 | PAK6 | 2.17697052 |
| 11 | NTRK2 | 2.16025900 |
| 12 | MAP2K4 | 2.15490044 |
| 13 | PRKD3 | 1.95432284 |
| 14 | KSR2 | 1.92445074 |
| 15 | CASK | 1.88268459 |
| 16 | PNCK | 1.86056318 |
| 17 | NTRK1 | 1.81909466 |
| 18 | FGFR2 | 1.76893054 |
| 19 | TNIK | 1.76548800 |
| 20 | CAMKK1 | 1.64439716 |
| 21 | ARAF | 1.47103946 |
| 22 | * CDK5 | 1.44855127 |
| 23 | KSR1 | 1.42112288 |
| 24 | GRK5 | 1.37243470 |
| 25 | DAPK1 | 1.36562989 |
| 26 | STK38 | 1.35707687 |
| 27 | PLK2 | 1.34466935 |
| 28 | CDK19 | 1.33037280 |
| 29 | MAP3K2 | 1.31852065 |
| 30 | MAP3K13 | 1.31630507 |
| 31 | MAPK13 | 1.24720088 |
| 32 | FES | 1.23298509 |
| 33 | LMTK2 | 1.23241691 |
| 34 | FGFR3 | 1.22824334 |
| 35 | PHKG2 | 1.20505578 |
| 36 | PHKG1 | 1.20505578 |
| 37 | SIK2 | 1.17767120 |
| 38 | PRPF4B | 1.16673087 |
| 39 | PRKCG | 1.15553085 |
| 40 | UHMK1 | 1.14523954 |
| 41 | CAMK2A | 1.04346391 |
| 42 | RIPK4 | 1.00981003 |
| 43 | CAMKK2 | 1.00484760 |
| 44 | CAMK1D | 1.00156413 |
| 45 | CAMK1 | 0.98925421 |
| 46 | PRKCH | 0.98437386 |
| 47 | CAMK1G | 0.98076066 |
| 48 | LATS2 | 0.96085714 |
| 49 | FGFR4 | 0.94859391 |
| 50 | PAK3 | 0.94324181 |
| 51 | SGK494 | 0.92646322 |
| 52 | SGK223 | 0.92646322 |
| 53 | CAMK4 | 0.92362940 |
| 54 | STK11 | 0.90878725 |
| 55 | PDGFRA | 0.90745592 |
| 56 | LATS1 | 0.88080128 |
| 57 | WNK3 | 0.84005880 |
| 58 | TNK2 | 0.82878309 |
| 59 | MAP3K1 | 0.81767052 |
| 60 | OXSR1 | 0.81435189 |
| 61 | RET | 0.81340401 |
| 62 | PINK1 | 0.81241384 |
| 63 | SGK2 | 0.80745193 |
| 64 | TYRO3 | 0.79490588 |
| 65 | CDK14 | 0.77573007 |
| 66 | CDK18 | 0.76980955 |
| 67 | CDK15 | 0.75477557 |
| 68 | CSNK1G2 | 0.74173705 |
| 69 | SGK3 | 0.72925935 |
| 70 | TIE1 | 0.72118108 |
| 71 | SGK1 | 0.70776800 |
| 72 | CAMK2B | 0.69464707 |
| 73 | NME1 | 0.69341559 |
| 74 | TAOK1 | 0.65807603 |
| 75 | DYRK1A | 0.65153724 |
| 76 | CAMK2D | 0.65127657 |
| 77 | STK38L | 0.64781571 |
| 78 | CDK11A | 0.63640936 |
| 79 | PIK3CA | 0.63526815 |
| 80 | PDK1 | 0.62946944 |
| 81 | SCYL2 | 0.61814414 |
| 82 | STK39 | 0.61034314 |
| 83 | RAF1 | 0.59821136 |
| 84 | PRKCE | 0.58882259 |
| 85 | CDC42BPA | 0.58720415 |
| 86 | AKT3 | 0.57768038 |
| 87 | PDPK1 | 0.57544320 |
| 88 | PDGFRB | 0.57282111 |
| 89 | MARK2 | 0.57200813 |
| 90 | FER | 0.55871706 |
| 91 | CCNB1 | 0.55052479 |
| 92 | WNK1 | 0.54681467 |
| 93 | ICK | 0.54348715 |
| 94 | ALK | 0.53405292 |
| 95 | RPS6KA3 | 0.53107478 |
| 96 | PRKCZ | 0.51931101 |
| 97 | PRKG1 | 0.50666979 |
| 98 | CAMK2G | 0.48775716 |
| 99 | JAK1 | 0.48066701 |
| 100 | MAPK10 | 0.46990484 |
| 101 | NEK6 | 0.46395070 |
| 102 | FRK | 0.46358475 |
| 103 | MAP3K7 | 0.46230173 |
| 104 | PTK2B | 0.42798685 |
| 105 | CDK12 | 0.41929830 |
| 106 | MAP3K6 | 0.39838053 |
| 107 | BMPR2 | 0.39189403 |
| 108 | MYLK | 0.38622756 |
| 109 | FYN | 0.38232720 |
| 110 | FGFR1 | 0.37968968 |
| 111 | WNK4 | 0.37840569 |
| 112 | GRK7 | 0.37411355 |
| 113 | PRKAA2 | 0.36122511 |
| 114 | MAPK12 | 0.35985966 |
| 115 | PRKCB | 0.35367062 |
| 116 | MAP2K1 | 0.35308679 |
| 117 | ROCK2 | 0.35287642 |
| 118 | RIPK1 | 0.35049254 |
| 119 | PRKAA1 | 0.34904515 |
| 120 | CSNK1D | 0.34870070 |
| 121 | RPS6KA2 | 0.34738234 |
| 122 | PRKACA | 0.31927908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.69440533 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.57111598 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.94396830 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72021389 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62918021 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.56755629 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.49607126 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35969228 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.31902305 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.23657794 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22319927 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.19665487 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.18157959 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.06422456 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05931948 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.86328292 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81711786 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.79528138 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74990866 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.73157128 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.72657038 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.69266515 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63293740 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60931140 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60625246 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.55356385 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.54034226 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45378124 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40986481 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27461335 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26971625 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.25091927 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23390310 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21912306 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19727443 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19331971 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.18318654 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17870130 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14643772 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13059214 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06010611 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03509328 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02897547 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01090706 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97891319 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96599588 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.94075748 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91902623 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89197252 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88824929 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88541706 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.87913135 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.86375482 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83272706 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82937671 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81858989 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81276795 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79856741 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73645889 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73063818 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69704650 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69265306 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.68853323 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66739875 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66309065 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65517857 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63721763 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62516806 |
| 69 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62320913 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.61109553 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.59172475 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59138924 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57592240 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57257923 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56913736 |
| 76 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54859999 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54585006 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.54076703 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51907046 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51593398 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.50789084 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50223262 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49571489 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.49558591 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47930993 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.47327235 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47326871 |
| 88 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.47145623 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46887643 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44419819 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44381375 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44148802 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44045265 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43908497 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42450153 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42312052 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41855481 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41334334 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41031762 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40599766 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39295979 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38761851 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38091796 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.38014215 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.37874532 |
| 106 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37732775 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37428127 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37052613 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36236398 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36058188 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35804594 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35661959 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35552969 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35352938 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35074187 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33058384 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33038731 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30325822 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27698611 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27560943 |

